A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/1997
12/10/1997	CN1167438A Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies
12/10/1997	CN1167436A Low-pressure tableted effervescent preparation
12/10/1997	CN1167126A Blends containing absorbable polyoxaamides
12/10/1997	CN1166979A High-efficiency medicine for burn and scald
12/10/1997	CN1166965A Liquid for stopping smoking and making method thereof
12/10/1997	CN1166962A Method for preparing fragrant anti-fungus medicine
12/10/1997	CN1166928A Method for preparation of medicinal and healthful fruit jelly
12/10/1997	CN1036632C Process for preparing composition containing oral cephalosporin crystal hydrate
12/09/1997	US5696277 Antiviral prodrugs
12/09/1997	US5696172 Containing complexing agent, preservative and ph adjuster to maintain ph between 7.5 and 8.5 for oxidation resistance and storage stability
12/09/1997	US5696165 Composition of s(-) sodium ibuprofen
12/09/1997	US5696164 Antifungal treatment of nails
12/09/1997	US5696109 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
12/09/1997	US5696095 Contains potassium acesulfame; masks bitterness without adversely affecting bioavailability or stability
12/09/1997	US5696090 Pharmaceutical composition
12/09/1997	US5696086 Administering before or after chemotherapy to promote thrombocyte production, also kits
12/09/1997	US5696000 Adhesion receptors for pathogenic or opportunistic microorganisms
12/09/1997	US5695955 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
12/09/1997	US5695784 Flavor-masked pharmaceutical compositions
12/09/1997	US5695782 Double-layered oxcarbazepine tablets
12/09/1997	US5695781 Sustained release formulation containing three different types of polymers
12/09/1997	US5695780 Cationic phospholipids for transfection
12/09/1997	US5695779 Release controlled transdermal therapeutic system
12/09/1997	US5695778 Calcipotriol as active substance
12/09/1997	US5695770 Induction of cytotoxic T-lymphocyte responses
12/09/1997	US5695749 Oil-free edible bar comprising anticholesterol agent and starch, bran filler
12/09/1997	US5695744 Medicaments
12/09/1997	US5695743 Medicinal aerosol formulations
12/09/1997	US5694947 Intravaginal delivery system
12/09/1997	CA2135922C Quick-change tool holder with center-height adjustment mechanism
12/04/1997	WO1997045537A1 A process for encapsulating viable animal cells
12/04/1997	WO1997045442A1 Polycationic sterol derivatives as transfection agents
12/04/1997	WO1997045367A1 Dissolvable oxides for biological applications
12/04/1997	WO1997045138A1 New improved formulation for treatment of thromboembolism
12/04/1997	WO1997045135A1 Stable pharmaceutical composition of bdnf
12/04/1997	WO1997045132A1 Antiviral agent, process for production thereof, and application thereof
12/04/1997	WO1997045131A1 Compositions for use in embolizing blood vessels
12/04/1997	WO1997045130A1 Methods for sterilizing female mammals
12/04/1997	WO1997045129A1 Methods for sterilizing male mammals
12/04/1997	WO1997045124A1 Pharmaceutical compositions
12/04/1997	WO1997045123A1 Topical pharmaceutical formulations comprising aciclovir
12/04/1997	WO1997045122A1 Suppositories
12/04/1997	WO1997045121A1 Preparation for percutaneous administration
12/04/1997	WO1997045105A1 Compositions and methods for treating or preventing diseases of body passageways
12/04/1997	WO1997045102A1 Novel therapeutic use of ophthalmic gels
12/04/1997	WO1997045091A2 Sustained release oxycodone formulations with no fed/fast effect
12/04/1997	WO1997045069A1 Cationic polymer/lipid nucleic acid delivery vehicles
12/04/1997	WO1997038689A3 Enteric-coated pharmaceutical compositions of mycophenolate
12/04/1997	WO1997038679A3 Fast disintegrating oral dosage form
12/04/1997	WO1997037689A3 Denaturants for sympathomimetic amine salts
12/04/1997	WO1997037638A3 Process for producing small doses of fluid and/or directly compressible powder systems
12/04/1997	WO1997035568A3 Diclofenac/gamma-cyclodextrin inclusion compounds
12/04/1997	CA2256900A1 Cationic polymer/lipid nucleic acid delivery vehicles
12/04/1997	CA2253410A1 New improved formulation for treatment of thromboembolism
12/04/1997	CA2252718A1 Compositions for use in embolizing blood vessels
12/03/1997	EP0809995A1 New diacerhein formulations obtained by active principle inclusion in polysaccharide hydrogels
12/03/1997	EP0809803A1 Three-dimensional colorimetric assay assemblies
12/03/1997	EP0809705A1 Nucleic acid-containing composition, preparation and use thereof
12/03/1997	EP0809627A1 Novel borneol derivatives, methods of manufacturing them, and their pharmaceutical use
12/03/1997	EP0809515A1 Therapeutic inhibitor of vascular smooth muscle cells
12/03/1997	EP0809512A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
12/03/1997	EP0809501A1 Novel pharmaceutical formulation
12/03/1997	EP0809498A1 Novel pharmaceutical combination
12/03/1997	EP0809497A1 Extended-release solid oral dosage forms of drugs having low solubility in water
12/03/1997	EP0809489A1 Medicament form for the delivery of collagenase to wounds and process for the preparation thereof
12/03/1997	EP0809488A1 Solid active agent preparations
12/03/1997	EP0809487A1 Solid active agent preparations containing hydroxypropyl cellulose
12/03/1997	EP0809486A1 Bio-erodible ophthalmic shield
12/03/1997	EP0797433A4 Gas filled microspheres as magnetic resonance imaging contrast agents
12/03/1997	EP0731679A4 Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
12/03/1997	EP0719286B1 Dextran esters, process for producing them and their use for encasing and encapsulating medicaments
12/03/1997	EP0651667B1 Medication administering device
12/03/1997	CN2269220Y Medicinal film for vagina
12/03/1997	CN2269214Y Adhesive plaster for curing wind-dampness syndrome
12/03/1997	CN1166788A Genetic material containing composition
12/03/1997	CN1166787A Lubeluzole intravenous solutions
12/03/1997	CN1166785A Pharmaceutical control of inflammation
12/03/1997	CN1166504A Absorbable polyoxaesters
12/03/1997	CN1166375A Process and apparatus for agglomeration of hydrolytically sensitive substances by means of steam
12/03/1997	CN1166351A Soft antilipemic capsule
12/03/1997	CN1166341A Multiple-effect ointment for treating various surgical diseases
12/03/1997	CN1166315A Complex spreading system for externally-used aerosol solution
12/03/1997	CN1166282A Composite taraxacum bagged-tea and its production process
12/03/1997	CN1036569C Method of producing skin-rubbing agent for curing the dysentery and diarrhoed of domestic animals
12/02/1997	US5693814 Crystals of antimicrobial compound
12/02/1997	US5693788 Desiccation and prevention of retrogradation using trehalose
12/02/1997	US5693775 Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
12/02/1997	US5693751 Water soluble high molecular weight polymerized drug preparation
12/02/1997	US5693676 Using nitroglycerin to treat anal fissures or ulcers, hemorrhoids, levator spasms
12/02/1997	US5693669 Dissolving tilidine in mixture of isopropanol and water, mild heating and stirring while adding phosphoric acid, then cooling and crystallization yields stable tilidine dihydrogen orthophosphate
12/02/1997	US5693625 Administering dextran functionalized with carboxymethyl groups and benzylamide or benzylamide sulfonate groups to skin or cornea
12/02/1997	US5693624 Sterile gel compositions for wound treatment
12/02/1997	US5693616 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
12/02/1997	US5693608 Method of administering a biologically active substance
12/02/1997	US5693516 Mixing with a surfactant and a water immiscible organic solvent to form a reverse micelle solution; evaporation to dryness
12/02/1997	US5693514 Non-fibrogenic high mannuronate alginate coated transplants, processes for their manufacture, and methods for their use
12/02/1997	US5693344 Insecticide comprising neurally effective fragrance and crystalline powder carrier of alkaline earth metal carbonate, alkali metal bicarbonate, absorbent
12/02/1997	US5693343 Mixing acetonitrile solutions of antigen-sucrose matrix and glycolide-lactide copolymer, then emulsification with an oil and centrifuging yields microspheres containing encapsulated antigen for orally administered vaccines
12/02/1997	US5693340 Diffusion-inhibiting, adhesive coating layer comprising chemical network having carbon or carbon and silicon atoms in chemically crosslinked relation
12/02/1997	US5693338 Delivery composition comprising active agent, diketopiperazine, enzyme inhibitor

1 ... 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 ... 2991